QualityStocksNewsBreaks Archives - Page 272 of 1531

ThursdayMar 14, 2024 2:37 pm

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in Key Study Assessing Proprietary AIMIGo(TM) System

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has begun enrolling the first patients in its VALID-ECG pivotal study. According to the announcement, the first patients were enrolled at Atlanta Heart Specialists, a top cardiology physician practice in Atlanta, Georgia. HeartBeam anticipates the VALID-ECG study will form the basis of its planned FDA 510(k) submission. The study is designed to evaluate the performance of a 12-lead ECG synthesized from the credit-card-sized HeartBeam AIMIGo(TM) system compared to a standard hospital-based 12-lead ECG; the study will use both quantitative and qualitative methodologies…

ThursdayMar 14, 2024 2:21 pm

QualityStocksNewsBreaks – Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Announces 508% Increase in 2023 PDP Reserve Valuation

Prospera (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) today announced a 508% increase to its proven developed producing (“PDP”) reserve value of 27MM$, reflecting the success of the company’s 2023 development program. In addition, Prospera’s proven plus probable (“2P”) reserve value increased by over 60MM$ to a total of 133MM$ – largely driven by the undeveloped reserve value increase from 58MM$ to $98MM$. InSite Petroleum Consultants Ltd. independently assessed PEI’s Dec. 31, 2023, year-end reserves in accordance with COGEH standards. Using a combination of vertical and horizontal wells, primarily in core assets located in Southwest and West-Central Saskatchewan (>42,000 acres), the…

ThursdayMar 14, 2024 1:58 pm

QualityStocksNewsBreaks – Correlate Energy Corp. (CIPI), Carbonsight Create Powerful Synergy, Empower Navigation to Low-Carbon Future

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, recently announced a strategic partnership with Carbonsight (by Autocase). “This move brings together Carbonsight’s cutting-edge decarbonization planning software and Correlate’s expertise in developing and financing renewable and clean energy projects, together helping businesses transition to a low-carbon future… Carbonsight is an online decarbonization planning tool specifically designed for real estate portfolios. It facilitates the development of building and portfolio plans to achieve carbon reduction targets. This allows building portfolio owners to organize pertinent data, quantify prospective CO2-reducing solutions, and visualize carbon reduction scenarios…

ThursdayMar 14, 2024 1:57 pm

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Announces Further Amendments to Iska Iska Payment Schedule

loro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), a leading exploration and mine development company, has amended the payment schedule for its Iska Iska silver-tin polymetallic project. The amendment was made by mutual agreement with Empresa Minera Villegas S.R.L., title holder of the project, which is located in the Potosi Department in southern Bolivia. This is the second time in the past month that Eloro Resources has announced amendments to the payment schedule. According to the announcement, Eloro’s Bolivian subsidiary, Minera Tupiza S.R.L., has made advance payments of $4.9 million to date toward the $10 million option payment. The schedule…

ThursdayMar 14, 2024 1:47 pm

QualityStocksNewsBreaks — D-Wave Quantum Inc. (NYSE: QBTS) Executives to Participate in 36th Annual Roth Conference

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, announced that CEO Dr. Alan Baratz and CFO John Markovich will present at the 36th Annual Roth Conference. The three-day event is scheduled for March 17–19, 2024, in Dana Point, California. According to the announcement, Dr. Baratz will also participate in a fireside chat scheduled for 1 p.m. PT on March 19. A replay of the fireside chat will be available following the presentation. To register for the fireside chat, visit https://ibn.fm/f5g7r To view the full press…

WednesdayMar 13, 2024 4:35 pm

QualityStocksNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) Offers Solutions to Combat Growing Cyber Risks

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, today outlined solutions to protect enterprise and small to medium-sized business (“SMB”) owners from the growing menace of bad actor cyber threats. Recent incidents, such as the alleged exploitation of Google accounts via OAuth2 functionality and the high-profile hacking of Microsoft’s corporate network from a Russian hacking group, highlight the crucial need for robust cybersecurity and data privacy measures. “As bad actor states continue to escalate their cyber threats, especially in the USA and during a presidential election year, businesses are facing unprecedented…

WednesdayMar 13, 2024 4:27 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Update on US Government Ruling for Class 1 EV Cargo Vans

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today provided an update on the U.S. Customs and Border Protection (“CBP”) application for Class 1 EV cargo vans. According to the announcement, the CBP, on March 5, 2024, informed Rapid Response Defense Systems (“RRDS”) counsel that a final determination on the ruling request needs to be issued by the U.S. General Services Administration (“GSA”). Based on CBP advice, Mullen and RRDS are proceeding with the GSA in order to finalize qualification of Mullen to sell Class 1 EV cargo vans to all branches of the U.S. government. “Mullen is…

WednesdayMar 13, 2024 4:11 pm

QualityStocksNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Shares Vision, Innovations in ASD Treatments in Updated Company Presentation

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced the release of its latest company presentation. The comprehensive overview showcases PaxMedica’s strategic direction, recent advancements in autism spectrum disorder (“ASD”) therapeutics, and its commitment to addressing unmet needs within the ASD community. “PaxMedica is pleased to share our vision and progress with the wider community,” said Howard Weisman, chairman and CEO of PaxMedica. “We believe that our work has the potential to transform the treatment landscape for ASD, offering a new horizon of hope and support for affected individuals and their loved ones.” To…

WednesdayMar 13, 2024 3:29 pm

QualityStocksNewsBreaks – ECGI Holdings Inc. (ECGI) Continues Initiative to Achieve Financial Optimization, Unlock Growth Opportunities

ECGI Holdings (OTC: ECGI), a diversified holding company, is continuing its initiative to strengthen its financial structure and boost shareholder value with further advancements. The company noted that it continues to build on its efforts, which have so far resulted in the successful identification and reduction of more than $600,000 in liabilities. The company has now identified an estimated additional $1,500,000 in liabilities for reduction, stemming from its strategic negotiations leading to the cancellation of purchase orders related to the acquisition of the East West Pharma Group. The significant reduction in liabilities and ongoing cleanup of ECGI’s balance sheet is expected to have a…

WednesdayMar 13, 2024 12:17 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces FY 2023 Results, Recent Operating Highlights

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today announced its full year 2023 financial results. In addition, the company provided recent operating highlights for the clinical programs in amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). “In 2024 we will continue to advance our regulatory discussions with the U.S. Food and Drug Administration (‘FDA’) that we anticipate will include new data on biomarkers, as well as additional clinical function and survival data in people…

Site Search

Company Search

Category: QualityStocksNewsBreaks